Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs. Diclofenac in Osteoarthritis
NCT00092703Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in osteoarthritis (OA) (2 arms), sponsored by Organon & Co. Primary endpoint: Discontinuations due to clinical and laboratory gastrointestinal adverse experiences at 1 year. Started Jun 2002; status: completed.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00092703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092703.